Baystate Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Baystate Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$91.4K	Buy	672 +145	+28%	+$17.7K	0.01%	287
2023 Q3	$64.5K	Hold	527	–	–	0.01%	307
2023 Q2	$67K	Hold	527	–	–	0.01%	303
2023 Q1	$68.2K	Hold	527	–	–	0.01%	295
2022 Q4	$69K	Hold	527	–	–	0.01%	291
2022 Q3	$62K	Hold	527	–	–	0.01%	286
2022 Q2	$62K	Hold	527	–	–	0.01%	297
2022 Q1	$69K	Hold	527	–	–	0.01%	285
2021 Q4	$80K	Hold	527	–	–	0.01%	267
2021 Q3	$85K	Hold	527	–	–	0.01%	236
2021 Q2	$86K	Hold	527	–	–	0.01%	222
2021 Q1	$79K	Sell	527 -36	-6%	-$5.72K	0.01%	217
2020 Q4	$85K	Hold	563	–	–	0.01%	189
2020 Q3	$76K	Hold	563	–	–	0.01%	180
2020 Q2	$77K	Buy	563 +36	+7%	+$4.59K	0.01%	181
2020 Q1	$57K	Hold	527	–	–	0.01%	183
2019 Q4	$64K	Hold	527	–	–	0.01%	202
2019 Q3	$52K	Buy	527 +1	+0.2%	+$105	0.01%	200
2019 Q2	$58K	Hold	526	–	–	0.01%	197
2019 Q1	$56K	Hold	526	–	–	0.01%	200
2018 Q4	$58K	Hold	526	–	–	0.01%	184
2018 Q3	$59K	Sell	526 -1	-0.2%	-$118	0.01%	181
2018 Q2	$61K	Buy	527 +1	+0.2%	+$107	0.01%	169
2018 Q1	$55K	Buy	526 +76	+17%	+$8.42K	0.01%	184
2017 Q4	$52K	Hold	450	–	–	0.01%	198
2017 Q3	$51K	Hold	450	–	–	0.01%	186
2017 Q2	$47K	Hold	450	–	–	0.01%	182
2017 Q1	$44K	Hold	450	–	–	0.01%	187
2016 Q4	$42K	Buy	+450	New	+$41K	0.01%	159
2013 Q3	–	Sell	-450	Closed	-$26K	–	109
2013 Q2	$26K	Buy	+450	New	+$26K	0.01%	136

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Baystate Wealth Management's IBB Position: Q4 2023 in Review

Baystate Wealth Management increased its iShares Biotechnology ETF (IBB) stake by 28% in Q4 2023, buying an estimated $17.7K and bringing the position to 672 shares worth $91.4K. The position accounts for 0.01% of the portfolio, ranked #287.

Baystate Wealth Management first reported a position in IBB in Q2 2013 and has held it in 30 quarters since. 872 funds tracked by Wall St. Rank hold IBB as of Q4 2023.

Baystate Wealth Management held 672 shares of iShares Biotechnology ETF worth $91.4K as of Q4 2023.
Baystate Wealth Management bought 145 iShares Biotechnology ETF shares in Q4 2023, an estimated $17.7K.
iShares Biotechnology ETF made up 0.01% of Baystate Wealth Management's portfolio in Q4 2023, its #287 holding.
Baystate Wealth Management first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 30 quarters since.
872 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2023.

Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.